arrow
J

Jason M. Redman

national institutes of health (nih) - usa
H指数:20
被引数:1,847

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The quadruple immunotherapy for colorectal cancer (QuICC) trial for mismatch repair-proficient metastatic colorectal cancer

针对错配修复 proficient 的转移性结直肠癌的四联免疫疗法(QuICC)试验

2026-03-012
PRE
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer

PRGN-2009和bintrafusp alfa用于晚期或转移性人乳头瘤病毒相关癌症患者

2025-03-210
OA
Tri-Ad5 vaccine plus bintrafusp alfa for newly diagnosed, advanced-stage head and neck cancer not associated with human papillomavirus infection

Tri-Ad5疫苗联合bintrafusp alfa治疗新诊断、晚期且与人乳头状瘤病毒感染无关的头颈部癌症

2025-03-010
PRE
Results from the quick efficacy seeking trial (QuEST1) arm combining BN-brachyury (BNVax) plus bintrafusp alfa (BA) plus nogapendekin alfa inbakicept-pmln (N-803) in castration-resistant prostate cancer (CRPC)

卡卢他法(BN-brachyury, BNVax)联合贝兰他法(bintrafusp alfa, BA)以及诺加肽(nogapendekin alfa inbakicept-pmln, N-803)在去势抵抗性前列腺癌(CRPC)的快速疗效探索试验(QuEST1)分支中的结果

2024-09-010
PRE
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics

一种深度学习框架,通过转录组学预测组织病理学图像的癌症治疗反应

2024-07-035
OA
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer (vol 132, e161400, 2022)
2023-06-013
PRE
Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
2022-09-1534
OAAI
Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies
2020-12-15106
OAAI
A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer
2020-07-012
OAAI
A phase Ib trial of sequential combinations of BN-brachyury, entinostat, ado-trastuzumab emtansine (T-DM1) and bintrafusp alfa (M7824) in advanced stage breast cancer (BrEAsT)
2020-02-152
PRE
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
2019-08-1547
OAAI
Phase I evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus (HPV)-associated malignancies
2019-07-0113
PRE